Surgepays, INC Form 4 insider transactions

Director David May acquired 40,250 shares of SurgePays, Inc. common stock through open market purchases.

SurgePays, Inc. reports that CEO Kevin Brian Cox was awarded 500,000 shares of common stock on June 1, 2026, as part of his employment agreement.

Kevin Brian Cox, CEO and Chairman of SurgePays, Inc., acquired over 1.3 million shares through debt conversion and awards, subsequently transferring some to a family trust.

SurgePays, Inc. Chief Financial Officer Anthony Evers was granted 200,000 restricted stock units vesting on December 31, 2025.

SurgePays, Inc. Director David Allen May acquired 38,422 shares of common stock through open market purchases on December 10, 2025.

SurgePays, Inc. Director David Allen May reported the sale of 63,000 shares of the company's common stock on June 6, 2025, at an average price of $2.814 per share.

SurgePays, Inc. Director David N. Keys was awarded 50,000 restricted shares of common stock on May 22, 2025, increasing his beneficial ownership to 67,043 shares.

SurgePays, Inc. director Laurie Weisberg was granted 50,000 restricted common shares on May 22, 2025, as part of the company's 2022 Omnibus Securities and Incentive Plan.

SurgePays, Inc. Director Richard Earl Schurfeld was granted 50,000 restricted shares of common stock as part of the company's 2022 Omnibus Securities and Incentive Plan.

SurgePays CEO and Chairman Kevin Brian Cox purchased 15,073 shares of common stock at an average price of $2.75 per share on May 16, 2025.

SurgePays CEO Kevin Brian Cox sold 35,180 shares of common stock to cover taxes associated with the vesting of restricted share awards.

SurgePays' Chief Financial Officer, Anthony Evers, sold 36,666 shares of common stock at $1.86 per share to cover taxes related to vesting of restricted share awards.

Director Laurie Weisberg of SurgePays, Inc. has acquired additional shares of common stock through several transactions in late November 2024.

Director Richard Schurfeld of SurgePays, Inc. has increased his holdings through recent purchases of common stock.

SurgePays CFO, Anthony Evers, sold 36,667 shares of common stock at $1.60 per share to cover taxes related to vesting of restricted share awards.

SurgePays CEO Kevin Brian Cox sold 31,700 shares of common stock at an average price of $1.595 to cover taxes related to vesting of restricted share awards.

SurgePays CEO Kevin Brian Cox reports acquisition of restricted stock and sale of shares to cover taxes.

Anthony Evers, CFO of SurgePays, Inc., reports acquisition of restricted shares and sale of common stock to cover taxes.

Richard Schurfeld, a director at SurgePays, Inc., reported the sale of warrants and the purchase of common stock in a recent SEC filing.

Anthony Evers, CFO of SurgePays, Inc., reports acquisition and disposal of company stock, including restricted shares, to cover taxes.

SurgePays CEO Kevin Brian Cox sold 35,100 shares to cover taxes related to the vesting of restricted stock awards, while also receiving an RSA grant of 83,333 shares.

Anthony Evers, CFO of SurgePays, Inc., reports the acquisition and disposal of company stock, including transactions to cover taxes related to vesting restricted share awards.

SurgePays CEO Kevin Brian Cox reports acquisition of restricted stock and sale of shares to cover taxes.

SurgePays' Chief Financial Officer, Anthony George Evers, disposed of 2,000 shares of common stock at a price of $3 per share on July 15, 2024.

Anthony Evers, CFO of SurgePays, Inc., sold 2,000 shares of common stock on July 11, 2024, at a price of $3 per share.

SurgePays CFO Anthony Evers reports acquisition of restricted shares and sale of common stock to cover taxes.

CEO and Chairman of the Board of SurgePays, Inc., Kevin Brian Cox, reports acquisition and disposal of shares, including restricted stock awards and sales to cover taxes.

Anthony Evers, CFO of SurgePays, Inc., reports the acquisition of restricted stock awards under the company's 2022 Omnibus Securities and Incentive Plan.

SurgePays CEO and Chairman Kevin Brian Cox reports the acquisition of 83,334 restricted shares on June 1, 2024, as part of an RSA grant.

SurgePays CEO and Chairman Kevin Brian Cox reports the acquisition of 83,334 restricted shares on May 1, 2024, as part of a pre-defined vesting schedule.